1. Home
  2. ZTS

as of 12-16-2025 3:30pm EST

$123.93
+$2.95
+2.44%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Chart Type:
Time Range:
Founded: 1952 Country:
United States
United States
Employees: N/A City: PARSIPPANY
Market Cap: 66.2B IPO Year: 2013
Target Price: $174.60 AVG Volume (30 days): 5.0M
Analyst Decision: Buy Number of Analysts: 11
Dividend Yield:
1.79%
Dividend Payout Frequency: Quarterly
EPS: 5.94 EPS Growth: 11.64
52 Week Low/High: $115.25 - $181.85 Next Earning Date: 11-04-2025
Revenue: $9,397,000,000 Revenue Growth: 2.68%
Revenue Growth (this year): 3.11% Revenue Growth (next year): 5.14%

AI-Powered ZTS Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 21 hours ago

AI Recommendation

hold
Model Accuracy: 69.08%
69.08%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Zoetis Inc. News

ZTS Breaking Stock News: Dive into ZTS Ticker-Specific Updates for Smart Investing

All ZTS News

Share on Social Networks: